Estados financieros detallados de KORU Medical Systems, Inc. (KRMD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
KORU Medical Systems, Inc. registró ingresos de $41.1M en el último ejercicio fiscal, con un CAGR de 5 años del 11.2%.
Márgenes de los últimos 12 meses: margen bruto 62.0%, margen operativo -3.7%, margen neto -4.0%.
Al precio actual de $3.22, KRMD presenta beneficios negativos (P/E no significativo) y un ROE del -10.63%. La capitalización bursátil es de $148M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $12.3M | $16.0M | $17.4M | $23.2M | $24.2M | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Coste de Ventas | $4.7M | $6.5M | $6.5M | $8.3M | $9.2M | $9.7M | $12.5M | $11.8M | $12.3M | $15.5M |
| Beneficio Bruto | $7.6M | $9.5M | $10.8M | $14.9M | $14.9M | $13.8M | $15.4M | $16.7M | $21.3M | $25.6M |
| I+D | $237486 | $60704 | $241124 | $740475 | $1.3M | $2.5M | $5.0M | $5.7M | $5.3M | $4.4M |
| Generales y Administrativos | $7.8M | $7.9M | $8.2M | $9.8M | 0 | 0 | 0 | 0 | 0 | $23.4M |
| Gastos Operativos | $8.3M | $8.0M | $8.7M | $10.9M | $16.2M | $20.8M | $26.1M | $27.0M | $27.8M | $28.6M |
| Beneficio Operativo | -$736251 | $1.5M | $1.2M | $585679 | -$1.3M | -$7.0M | -$10.8M | -$10.3M | -$6.4M | -$3.0M |
| EBITDA | -$474202 | $1.9M | $2.4M | $4.3M | $1.6M | -$5.9M | -$10.1M | -$8.9M | -$5.3M | -$1.8M |
| Gastos por Intereses | $1886 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$776699 | $1.6M | $1.2M | $696418 | -$1.2M | -$6.4M | -$10.7M | -$9.8M | -$6.1M | -$2.6M |
| Impuestos | -$241700 | $483075 | $266380 | $132069 | $17800 | -$1.8M | -$2.0M | $4.0M | $2893 | $21890 |
| Beneficio Neto | -$535000 | $1.1M | $910570 | $564349 | -$1.2M | -$4.6M | -$8.7M | -$13.7M | -$6.1M | -$2.6M |
| BPA | $-0.01 | $0.03 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | $-0.06 |
| BPA Diluido | $-0.01 | $0.03 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | $-0.06 |
| Acciones en Circulación (Diluidas) | $37.9M | $38.4M | $38.9M | $39.1M | $41.9M | $44.4M | $45.0M | $45.6M | $45.8M | $46.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $10.4M | $10.9M | $11.8M | $12.0M |
| Beneficio Bruto | $6.3M | $6.8M | $7.0M | $7.8M |
| Beneficio Operativo | -$867679 | -$547104 | -$864923 | $626991 |
| EBITDA | -$573634 | -$302998 | -$609547 | $468279 |
| Beneficio Neto | -$777966 | -$486856 | -$807078 | $252449 |
| BPA | $-0.02 | $-0.01 | $-0.02 | $0.01 |
| BPA Diluido | $-0.02 | $-0.01 | $-0.02 | $0.01 |
Balance (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $3.3M | $4.0M | $3.7M | $5.9M | $27.3M | $25.3M | $17.4M | $11.5M | $9.6M | $8.9M |
| Inversiones a Corto | $262314 | $263269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1.7M | $1.9M | $1.4M | $3.2M | $2.6M | $3.6M | $3.6M | $4.0M | $6.0M | $6.5M |
| Inventario | $1.4M | $1.7M | $2.1M | $2.4M | $6.8M | $6.1M | $6.4M | $3.5M | $2.8M | $3.7M |
| Activos Corrientes | $6.8M | $7.9M | $9.0M | $11.9M | $37.5M | $37.3M | $29.8M | $20.3M | $19.1M | $20.0M |
| Inmovilizado Material | $932092 | $836283 | $858781 | $985580 | $1.4M | $1.2M | $7.7M | $7.4M | $7.3M | $7.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $426943 | $483821 | $632156 | $807135 | $843587 | $808813 | $787182 | $754361 | $730279 | $684841 |
| Activos Totales | $8.2M | $9.3M | $10.5M | $13.9M | $39.9M | $41.3M | $42.3M | $28.5M | $27.2M | $28.2M |
| Cuentas por Pagar | $772428 | $454398 | $453498 | $572656 | $624920 | $1.2M | $2.4M | $975193 | $1.6M | $2.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $508583 | $433295 | $314344 | $271152 | $538361 |
| Pasivos Corrientes | $1.4M | $1.6M | $1.6M | $2.4M | $3.7M | $4.8M | $7.0M | $4.5M | $7.2M | $8.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M |
| Pasivos Totales | $1.5M | $1.6M | $1.6M | $2.6M | $3.8M | $4.8M | $11.0M | $8.1M | $10.4M | $11.2M |
| Reservas | $2.5M | $3.4M | $4.3M | $4.9M | $3.7M | -$910069 | -$9.6M | -$23.3M | -$29.4M | -$32.0M |
| Patrimonio Neto | $6.7M | $7.7M | $9.0M | $11.2M | $36.2M | $36.5M | $31.3M | $20.4M | $16.8M | $17.0M |
| Deuda Total | 0 | 0 | 0 | $381676 | $239492 | $604136 | $4.9M | $4.4M | $4.0M | $3.5M |
| Deuda Neta | -$3.6M | -$4.2M | -$3.7M | -$5.5M | -$27.1M | -$24.7M | -$12.5M | -$7.0M | -$5.6M | -$5.4M |
| Capital Circulante | $5.4M | $6.3M | $7.4M | $9.5M | $33.9M | $32.5M | $22.8M | $15.8M | $11.9M | $11.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $8.5M | $8.9M | $8.8M | $8.3M |
| Activos Totales | $27.1M | $28.2M | $28.6M | $28.0M |
| Pasivos Totales | $10.6M | $11.2M | $11.7M | $9.9M |
| Patrimonio Neto | $16.5M | $17.0M | $16.9M | $18.1M |
| Deuda Total | $3.7M | $3.5M | $3.4M | $3.2M |
Flujo de Caja (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$535000 | $1.1M | $910570 | $564349 | -$1.2M | -$4.6M | -$8.7M | -$13.7M | -$6.1M | -$2.6M |
| Amortizaciones | $300611 | $308708 | $309263 | $340229 | $418595 | $463130 | $587137 | $870390 | $888473 | $810500 |
| Compensación en Acciones | $205486 | $129700 | $366081 | $1.2M | $1.6M | $2.7M | $3.1M | $2.8M | $2.6M | $2.7M |
| Cambio en Capital Circulante | -$248185 | -$349845 | -$16134 | -$1.5M | -$2.9M | -$1.1M | $1.4M | $1.2M | $2.0M | -$319168 |
| Flujo de Caja Operativo | -$331616 | $899912 | $1.5M | $320620 | -$743323 | -$4.3M | -$5.4M | -$4.9M | -$319718 | $462405 |
| Inversiones (CapEx) | -$415133 | -$218326 | -$481166 | -$425539 | -$1.1M | -$375234 | -$2.8M | -$814597 | -$1.3M | -$932517 |
| Adquisiciones | 0 | 0 | $481166 | $217821 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$140739 | -$19360 | -$36821 | -$2820 | -$3.5M | 0 | 0 | 0 | -$97379 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$746749 | $681586 | $998496 | -$104919 | -$1.8M | -$4.7M | -$8.2M | -$5.7M | -$1.6M | -$470112 |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $65456 | $1.1M | $14663 | $216113 |
| Inversiones (CapEx) | -$52486 | -$407782 | -$89885 | -$577367 |
| Flujo de Caja Libre | $12970 | $686974 | -$75222 | -$361254 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $972812 | $681510 | $457774 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +30.0% | +8.6% | +33.5% | +4.4% | -2.8% | +18.8% | +2.2% | +18.0% | +22.2% |
| Crecimiento Beneficio Neto (anual) | | +303.0% | -16.1% | -38.0% | -314.8% | -276.5% | -89.8% | -58.7% | +55.9% | +56.5% |
| Crecimiento BPA (anual) | | +303.5% | -16.7% | -38.9% | -297.9% | -246.0% | -90.0% | -57.9% | +56.7% | +56.1% |
| Cambio en Acciones (anual) | | +1.4% | +1.4% | +0.4% | +7.3% | +5.9% | +1.4% | +1.3% | +0.4% | +0.8% |
| Crecimiento FCF (anual) | | +191.3% | +46.5% | -110.5% | -1619.9% | -160.2% | -74.8% | +30.5% | +71.7% | +70.9% |
| Margen Bruto | 61.6% | 59.2% | 62.3% | 64.1% | 61.8% | 58.6% | 55.1% | 58.6% | 63.4% | 62.3% |
| Margen Operativo | -6.0% | 9.3% | 6.7% | 2.5% | -5.2% | -29.9% | -38.6% | -36.0% | -19.2% | -7.2% |
| Margen EBITDA | -3.9% | 11.8% | 13.7% | 18.7% | 6.7% | -25.1% | -36.2% | -31.2% | -15.7% | -4.4% |
| Margen Neto | -4.4% | 6.8% | 5.2% | 2.4% | -5.0% | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% |
| Margen FCF | -6.1% | 4.3% | 5.8% | -0.5% | -7.5% | -20.0% | -29.4% | -20.0% | -4.8% | -1.1% |
| Tasa Impositiva Efectiva | 31.1% | 30.8% | 22.6% | 19.0% | -1.5% | 28.3% | 18.9% | -40.6% | -0.0% | -0.8% |
Datos por Acción (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.02 | $0.02 | $0.03 | $-0.00 | $-0.04 | $-0.11 | $-0.18 | $-0.13 | $-0.04 | $-0.01 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $37.8M | $37.9M | $38.1M | $38.8M | $41.9M | $44.4M | $45.0M | $45.6M | $45.8M | $46.2M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -10.63% |
| Rentabilidad sobre capital invertido | -7.74% |
| Rentabilidad sobre activos | -6.51% |
| Margen bruto | 61.99% |
| Margen operativo | -3.66% |
| Margen neto | -4.03% |
Salud financiera
| Deuda / Patrimonio | 0.18 |
| Ratio corriente | 2.72 |
Ratios Clave (10 años)
| Año | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -30.14 | 36.93 | 69.04 | 447.26 | -208.30 | -30.00 | -18.79 | -8.20 | -29.62 | -101.75 |
| P/VC | 2.41 | 5.23 | 7.02 | 22.54 | 6.98 | 3.65 | 5.13 | 5.51 | 10.49 | 15.74 |
| P/V | 1.31 | 2.51 | 3.63 | 10.93 | 10.44 | 5.67 | 5.76 | 3.93 | 5.24 | 6.52 |
| Margen Bruto | 61.6% | 59.2% | 62.3% | 64.1% | 61.8% | 58.6% | 55.1% | 58.6% | 63.4% | 62.3% |
| Margen Operativo | -6.0% | 9.3% | 6.7% | 2.5% | -5.2% | -29.9% | -38.6% | -36.0% | -19.2% | -7.2% |
| Margen Neto | -4.4% | 6.8% | 5.2% | 2.4% | -5.0% | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% |